marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q2
added 07-25-2024
NovoCure Limited Balance Sheet 2011-2024 | NVCR
Annual Balance Sheet NovoCure Limited
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
336 M | 456 M | 353 M | 184 M | 121 M | 114 M | 124 M | 116 M | 53.7 M | -57.3 M | -176 M | - | - |
Long Term Debt |
569 M | 566 M | 562 M | 430 M | 149 M | 149 M | 98 M | 96.2 M | 23.1 M | 321 K | 346 K | - | - |
Long Term Debt Current |
8.22 M | 5.8 M | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
605 M | 592 M | 586 M | 462 M | 175 M | 163 M | 102 M | 103 M | 27.9 M | 2.33 M | 1.53 M | - | - |
Total Current Liabilities |
179 M | 159 M | 143 M | 114 M | 86.3 M | 64.6 M | 50.2 M | 36.9 M | 28.6 M | - | - | - | - |
Total Liabilities |
784 M | 750 M | 729 M | 575 M | 262 M | 228 M | 152 M | 140 M | 56.5 M | 20 M | 17.1 M | - | - |
Deferred Revenue |
16.2 M | 18 M | - | - | 11.8 M | 8.84 M | 4.96 M | 2.27 M | - | - | - | - | - |
Retained Earnings |
-986 M | -778 M | -686 M | -631 M | -651 M | -644 M | -582 M | -520 M | -388 M | -276 M | -196 M | - | - |
Total Assets |
1.15 B | 1.19 B | 1.14 B | 1.05 B | 479 M | 340 M | 265 M | 282 M | 307 M | 118 M | 189 M | - | - |
Cash and Cash Equivalents |
241 M | 115 M | 209 M | 246 M | 177 M | 141 M | 78.6 M | 99.8 M | 119 M | 57.6 M | 176 M | - | - |
Book Value |
362 M | 441 M | 410 M | 477 M | 218 M | 112 M | 114 M | 142 M | 251 M | 97.9 M | 172 M | - | - |
Total Shareholders Equity |
362 M | 441 M | 410 M | 477 M | 218 M | 112 M | 114 M | 142 M | 251 M | 97.9 M | 172 M | - | - |
All numbers in USD currency
Quarterly Balance Sheet NovoCure Limited
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
21.7 M | 570 M | 27.4 M | 568 M | 567 M | 566 M | 566 M | 565 M | - | 563 M | 562 M | 561 M | 561 M | 560 M | 430 M | 430 M | 430 M | 430 M | 149 M | 149 M | 149 M | 149 M | 149 M | 149 M | 149 M | 149 M | 97.3 M | 97.3 M | 97.3 M | 97.3 M | 96.2 M | 96.2 M | 96.2 M | 96.2 M | 23.1 M | 23.1 M | 23.1 M | 23.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
681 M | 602 M | 605 M | 595 M | 593 M | 593 M | 592 M | 588 M | - | 587 M | 586 M | 583 M | 584 M | 585 M | 462 M | 462 M | 462 M | 462 M | 175 M | 175 M | 175 M | 175 M | 163 M | 163 M | 163 M | 163 M | 102 M | 102 M | 102 M | 102 M | 103 M | 103 M | 103 M | 103 M | 27.9 M | 27.9 M | 27.9 M | 27.9 M | 2.33 M | 2.33 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
850 M | 762 M | 784 M | 753 M | 743 M | 742 M | 750 M | 729 M | - | 714 M | 729 M | 707 M | 700 M | 695 M | 575 M | 575 M | 575 M | 575 M | 262 M | 262 M | 262 M | 262 M | 228 M | 228 M | 228 M | 228 M | 152 M | 152 M | 152 M | 152 M | 140 M | 140 M | 140 M | 140 M | 56.5 M | 56.5 M | 56.5 M | 56.5 M | 20 M | 20 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
15.6 M | 15.9 M | 16.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-1.06 B | -1.02 B | -986 M | -938 M | -889 M | -832 M | -778 M | -741 M | - | -691 M | -686 M | -659 M | -646 M | -632 M | -631 M | -631 M | -631 M | -631 M | -651 M | -651 M | -651 M | -651 M | -644 M | -644 M | -644 M | -644 M | -582 M | -582 M | -582 M | -582 M | -520 M | -520 M | -520 M | -520 M | -388 M | -388 M | -388 M | -388 M | -276 M | -276 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
1.21 B | 1.12 B | 1.15 B | 1.15 B | 1.16 B | 1.17 B | 1.19 B | 1.17 B | - | 1.15 B | 1.14 B | 1.12 B | 1.1 B | 1.07 B | 1.05 B | 1.05 B | 1.05 B | 1.05 B | 479 M | 479 M | 479 M | 479 M | 340 M | 340 M | 340 M | 340 M | 265 M | 265 M | 265 M | 265 M | 282 M | 282 M | 282 M | 282 M | 307 M | 307 M | 307 M | 307 M | 118 M | 118 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
165 M | 454 M | 241 M | 155 M | 157 M | 186 M | 115 M | 244 M | 368 M | 192 M | 209 M | 691 M | 361 M | 315 M | 235 M | 235 M | 235 M | 235 M | 177 M | 177 M | 177 M | 177 M | 141 M | 141 M | 141 M | 141 M | 78.6 M | 78.6 M | 78.6 M | 78.6 M | 99.8 M | 99.8 M | 99.8 M | 99.8 M | 119 M | 119 M | 119 M | 119 M | 57.6 M | 57.6 M | - | - | 176 M | - | - | - | 34.9 M | - | - | - | - | - | - | - |
Book Value |
362 M | 359 M | 362 M | 394 M | 416 M | 432 M | 441 M | 445 M | - | 436 M | 410 M | 413 M | 397 M | 372 M | 477 M | 477 M | 477 M | 477 M | 218 M | 218 M | 218 M | 218 M | 112 M | 112 M | 112 M | 112 M | 114 M | 114 M | 114 M | 114 M | 142 M | 142 M | 142 M | 142 M | 251 M | 251 M | 251 M | 251 M | 97.9 M | 97.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
362 M | 359 M | 362 M | 394 M | 416 M | 432 M | 441 M | 445 M | 442 M | 436 M | 410 M | 413 M | 397 M | 372 M | 477 M | 477 M | 477 M | 477 M | 218 M | 218 M | 218 M | 218 M | 112 M | 112 M | 112 M | 112 M | 114 M | 114 M | 114 M | 114 M | 142 M | 142 M | 142 M | 142 M | 251 M | 251 M | 251 M | 251 M | 97.9 M | 97.9 M | - | - | 172 M | - | - | - | 49.4 M | - | - | - | - | - | - | - |
All numbers in USD currency